Glitazones and Endothelial Function (GATE)
Condition(s):Diabetes MellitusLast Updated:November 2, 2008Terminated
Hide Studies Not Open or Pending
Condition(s):Diabetes MellitusLast Updated:November 2, 2008Terminated
Condition(s):Myocardial IschemiaLast Updated:March 26, 2024Completed
Condition(s):Coronary Artery Bypass Grafting; Coronary Artery Disease; Cardiac RehabilitationLast Updated:August 7, 2019Completed
Condition(s):Change in Flow Mediated DilationLast Updated:June 12, 2020Unknown status
Condition(s):Chest Pain; Major Adverse Cardiovascular EventsLast Updated:December 9, 2021Completed
Condition(s):Pregnancy Complications; Endothelial DysfunctionLast Updated:October 31, 2016Unknown status
Condition(s):Obesity; OverweightLast Updated:February 12, 2018Completed
Condition(s):Endothelial DysfunctionLast Updated:May 26, 2020Completed
Condition(s):COVID-19; MIS-C Associated With COVID-19Last Updated:January 25, 2022Recruiting
Condition(s):Childhood Obesity; InflammationLast Updated:April 24, 2015Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.